The mitochondrial relocation of CCNB1/CDK1 enhances the ATP production needed for DNA damage repair, aiding cell survival and contributing to tumor resistance to DNA-damaging treatments such as chemotherapy and radiotherapy [44]. This evidence concerns the gene CDK1 and neoplasm.